Office of Research

Alzheimer's Clinical Trials Consortium (ACTC) (U24)

Limited Submissions

This Funding Opportunity Announcement (FOA) invites applications to establish an Alzheimer's disease Clinical Trials Consortium (ACTC) that will run trials focused on interventions that may prevent, delay, or treat the symptoms of Alzheimer's disease (AD) and other age related dementias. The ACTC will include multiple clinical trials sites and trial coordination and management infrastructure. A separate FOA will solicit applications for clinical trials to be managed and supported by the ACTC.

 

The ACTC will conduct clinical trials (Phase I to III) of promising pharmacological and non- pharmacological interventions for cognitive and neuropsychiatric symptoms in individuals with AD and other age related dementias across the spectrum from pre-symptomatic to more severe stages of disease. The ACTC will provide a state-of-the-art clinical trial infrastructure to facilitate rapid development and implementation of protocols. The ACTC will also provide leadership to the field in innovative trial design methods, outcomes and analyses as well as recruitment strategies, particularly in diverse populations.  

Application Instructions

Please submit:

  1. a one-page letter of intent with a description of proposed aims and approach
  2. Biosketch or CV of the PI
  3. A letter of support from the Dean or Chair. This letter of support signifies that the Dean or Chair have ensured that the nominee and application are likely to be of sufficient quality to be competitive nationally

 

to research@uw.edu by 5:00 PM Thursday October 6, 2016. Full proposals are due to the sponsor 2/2/17 so you will need to have your materials in to the Office of Sponsored Programs by 1/25/17 for processing, if given the go ahead by the Proposal Review Committee.

Opportunity Details

Program web page

Program Announcement No.

RFA-AG-17-005

Deadlines
10/06/2016 UW Internal Deadline Closed
01/25/2017 OSP Deadline
02/02/2017 Sponsor Deadline
Sponsor

National Institutes of Health (NIH)

Funding amount

$16,777,215

Maximum Number of Applications

1

Eligible groups
  • All campus

Inquiries and Contact Information

Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.

For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.